Abbott Laboratories (ABT) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Abbott Laboratories

NYSE | ABT

125.40

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 4, 2025)

$218.06B

Market Cap

15.88

P/E Ratio

7.89

EPS

$139.33

52 Week High

$109.21

52 Week Low

HEALTHCARE

Sector

ABT Chart

Recent Chart

Price Action

ABT Technicals

Tags:

ABT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$21B
Total Revenue	$42B
Cost Of Revenue	$21B
Costof Goods And Services Sold	$21B
Operating Income	$6.8B
Selling General And Administrative	$12B
Research And Development	$2.8B
Operating Expenses	$14B
Investment Income Net	-
Net Interest Income	-$215M
Interest Income	$344M
Interest Expense	$603M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$3.2B
Income Before Tax	$7B
Income Tax Expense	-$6.4B
Interest And Debt Expense	-
Net Income From Continuing Operations	$13B
Comprehensive Income Net Of Tax	-
Ebit	$7.6B
Ebitda	$11B
Net Income	$13B

Revenue & Profitability

Earnings Performance

ABT Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$81B
Total Current Assets	$24B
Cash And Cash Equivalents At Carrying Value	$7.6B
Cash And Short Term Investments	$7.6B
Inventory	$6.2B
Current Net Receivables	$6.9B
Total Non Current Assets	$58B
Property Plant Equipment	$12B
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$6.6B
Intangible Assets Excluding Goodwill	$6.6B
Goodwill	$23B
Investments	-
Long Term Investments	$886M
Short Term Investments	$351M
Other Current Assets	$2.6B
Other Non Current Assets	-
Total Liabilities	$34B
Total Current Liabilities	$14B
Current Accounts Payable	$4.2B
Deferred Revenue	-
Current Debt	-
Short Term Debt	$1.8B
Total Non Current Liabilities	$19B
Capital Lease Obligations	$896M
Long Term Debt	$13B
Current Long Term Debt	$1.5B
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$15B
Other Current Liabilities	$7.6B
Other Non Current Liabilities	$3.4B
Total Shareholder Equity	$48B
Treasury Stock	-
Retained Earnings	$47B
Common Stock	$25B
Common Stock Shares Outstanding	$1.7B

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	$8.6B
Payments For Operating Activities	-
Proceeds From Operating Activities	-
Change In Operating Liabilities	-
Change In Operating Assets	-
Depreciation Depletion And Amortization	$3.2B
Capital Expenditures	$2.2B
Change In Receivables	-
Change In Inventory	-$58M
Profit Loss	-
Cashflow From Investment	-$2.3B
Cashflow From Financing	-$5.4B
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$3.8B
Dividend Payout Common Stock	$3.8B
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$1.3B
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$13B

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$21B
Total Revenue	$42B
Cost Of Revenue	$21B
Costof Goods And Services Sold	$21B
Operating Income	$6.8B
Selling General And Administrative	$12B
Research And Development	$2.8B
Operating Expenses	$14B
Investment Income Net	-
Net Interest Income	-$215M
Interest Income	$344M
Interest Expense	$603M
Non Interest Income	-
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$3.2B
Income Before Tax	$7B
Income Tax Expense	-$6.4B
Interest And Debt Expense	-
Net Income From Continuing Operations	$13B
Comprehensive Income Net Of Tax	-
Ebit	$7.6B
Ebitda	$11B
Net Income	$13B

Dividends

Field	Value
Ex Dividend Date	2025-10-15
Declaration Date	2025-09-19
Record Date	2025-10-15
Payment Date	2025-11-17
Amount	0.59

ABT News

ABT Profile

Abbott Laboratories Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Abbott Laboratories (ABT) is a prominent American multinational healthcare company based in Abbott Park, Illinois, with expertise across a diverse range of sectors, including medical devices, diagnostics, nutritional products, and branded generic medicines. Established in 1888, Abbott has demonstrated a strong commitment to innovation, enhancing health outcomes through cutting-edge technology and comprehensive healthcare solutions. The company's strategic decision to spin off its research-based pharmaceutical operations into AbbVie in 2013 has allowed it to focus on its core offerings while maintaining a legacy of excellence in healthcare. With a robust global presence, Abbott is well-positioned to capitalize on emerging market opportunities and address evolving healthcare needs.

Symbol	Price	Change %	Market Cap	Volume
LPTX	$2.05	+368.57%	$116.14M	760,562,526
PAVS	$0.03	-7.35%	$2.29M	225,963,111
KALA	$0.96	+4.21%	$7.59M	178,463,238
NVDA	$183.38	+2.11%	$4.37T	166,546,707
ASST	$0.97	-6.99%	$856.26M	130,414,171

Symbol	Price	Change %	Market Cap	Volume
JNJ	$202.48	-1.38%	$494.92B	8,763,737
PG	$145.36	-0.92%	$343.37B	10,159,325
MRK	$100.89	-1.34%	$255.45B	12,715,162
NVO	$47.99	+0.88%	$211.38B	18,385,103
BSX	$97.72	-0.86%	$146.12B	9,346,769

Symbol	Price	Change %	Market Cap	Volume
CELO	$0.00	+9900.00%	-	3,000
LPTX	$2.05	+368.57%	$116.14M	760,562,526
BACK	$0.18	+221.42%	$117.71K	275,845
SMX	$141.00	+141.06%	$61.45M	5,845,723
PLRZ	$14.50	+104.51%	$7.39M	26,134,632

Symbol	Price	Change %	Market Cap	Volume
SHOT	$0.39	-74.37%	$67.15M	13,958,900
PKBO	$0.02	-67.85%	$531.87K	66,140
ADN	$0.91	-66.10%	$3.02M	4,417,827
BUJA	$3.66	-65.76%	$18.09M	298,984
AXDX	$0.03	-61.36%	$859.92K	67,483,332

Quick Links

ABT $0.00 (+0.00% ) Quote details